Singapore, April 13 -- Almirall, S.A. (ALM), a global biopharmaceutical company dedicated to medical dermatology, has announced an expanded collaboration with the Barcelona Supercomputing Center - Centro Nacional de Supercomputación (BSC - CNS). This new framework agreement strengthens their partnership, aiming to accelerate research and development in medical dermatology by applying advanced supercomputing, High-Performance Computing (HPC), and Artificial Intelligence.

The collaboration is a testament to Almirall's commitment to pushing the boundaries of science to address the needs of patients with skin conditions. It builds on previous successful R&D joint projects and is framed within the broader research collaboration between B...